Innovative plate-based internalization reagents designed to deliver accurate, high-throughput, and scalable insights for GPCR and ADC research
The facility includes advanced laboratories to monitor market trends, consumer needs, product innovation, and formulation improvements
Fermenta now becomes one of the only two companies globally to hold a CEP for this variant of Vitamin D3
The latest BioE3 policy builds the framework for high-performance biomanufacturing to propel the development and production
This certification validates the plant’s robust capabilities in manufacturing a wide range of sterile dosage forms
The inspection was conducted from July 22-25, 2025
This GMP certification for our sterile drug product manufacturing facility, Goa Plant II is a testament to our relentless efforts to supply quality and affordable medicines across geographies
This collaboration aims to bridge India’s talent and translational gap in this rapidly growing field by equipping professionals with practical expertise in the manufacturing of advanced therapies.
The phase III ARNASA study did not meet the primary endpoint of a statistically significant reduction in the AER at 52 weeks
Longer-term follow up in the FLAURA2 Phase III trial confirms the favourable benefit-risk profile of this combination
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
